Akzo Nobel N.V.
AKZOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | 13.8% | 0.5% | -0.2% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 40.3% | 39.5% | 40.1% | 39.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 11.2% | 8.1% | 7.3% | 4.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -7.6% | 4.7% | 4.1% | 0.8% |
| EPS | -1.33 | 0.73 | 0.63 | 0.12 |
| % Growth | -282.2% | 15.9% | 425% | – |
| EPS Diluted | -1.33 | 0.72 | 0.62 | 0.12 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 1.3% | 12.9% | 11.2% | 8.6% |